MARKET

TLX

TLX

Telix Pharmaceuticals Ltd ADR
NASDAQ
9.24
-0.33
-3.45%
After Hours: 9.19 -0.05 -0.54% 16:54 04/01 EDT
OPEN
9.43
PREV CLOSE
9.57
HIGH
9.43
LOW
9.20
VOLUME
175.98K
TURNOVER
--
52 WEEK HIGH
20.00
52 WEEK LOW
6.28
MARKET CAP
3.13B
P/E (TTM)
-437.9147
1D
5D
1M
3M
1Y
5Y
1D
Telix files Form 3 for Group Chief Medical Officer Cade David Norman
Reuters · 16h ago
Telix files Form 3 for Group CFO Darren Charlton Smith initial beneficial ownership statement
Reuters · 16h ago
Telix Pharmaceuticals director Mark Nelson files initial beneficial ownership statement
Reuters · 16h ago
Telix files initial beneficial ownership statement for Group COO Darren Patti
Reuters · 16h ago
Weekly Report: what happened at TLX last week (0323-0327)?
Weekly Report · 2d ago
Thor Medical FY2025 annual report published; operating profit (EBIT) falls to NOK -70 million
Reuters · 5d ago
Heidelberg Pharma FY2025 annual report published; net loss widens to EUR -42 million
Reuters · 6d ago
Weekly Report: what happened at TLX last week (0316-0320)?
Weekly Report · 03/23 10:34
More
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Webull offers Telix Pharmaceuticals Ltd stock information, including NASDAQ: TLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLX stock methods without spending real money on the virtual paper trading platform.